These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6833458)

  • 1. Prolactin response to dopamine synthesis inhibition using monoiodotyrosine in subjects on oral contraceptives and patients with pathological hyperprolactinemia.
    Ho KY; Smythe GA; Lazarus L
    J Clin Endocrinol Metab; 1983 Apr; 56(4):692-6. PubMed ID: 6833458
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral contraceptives and prolactin-producing hypophyseal tumors].
    Lamberts SW
    Ned Tijdschr Geneeskd; 1980 Jan; 124(4):111-3. PubMed ID: 7374834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amenorrhea and the pill].
    Verdino P; Viard R; Harter M
    Lyon Mediterr Med Med Sud Est; 1983 Jan; 19(2):7067-74. PubMed ID: 12279701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Post-pill amenorrhea and prolactin].
    Volpe A; Baviera G; Montanari GD
    Riv Ital Ginecol; 1977; 58(4):247-52. PubMed ID: 756597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary prolactinoma and estrogen contraceptives.
    Vaisrub S
    JAMA; 1979 Jul; 242(2):177-8. PubMed ID: 12309457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Anovlar in gynaecological disorders and contraception.
    Shahani SM; Chiklikar A
    J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of combined oral contraceptives on prolactin blood levels (author's transl).
    Diaz AJ; Diaz MM; Bahamondes LG; Goto CT; Faundes A
    J Bras Ginecol; 1982; 92(3):139-42. PubMed ID: 12279320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation between oral contraceptive use and subsequent development of hyperprolactinemia.
    Badawy SZ; Rebscher F; Kohn L; Wolfe H; Oates RP; Moses A
    Fertil Steril; 1981 Oct; 36(4):464-7. PubMed ID: 7286268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive exposure of amenorrheic women with and without prolactinomas.
    Jones JR; Kemmann E; Norwood PK
    Int J Gynaecol Obstet; 1981 Oct; 19(5):381-7. PubMed ID: 6120108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated prolactin levels in oral contraceptive pill-related hypertension.
    Lehtovirta P; Ranta T; Seppälä M
    Fertil Steril; 1981 Apr; 35(4):403-5. PubMed ID: 6783445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some observations on the changes in capillary resistance in oral contraceptive users.
    Zaki K; Younis MN; Razek SA; Mekkawi TE; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):145-51. PubMed ID: 12256025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood prolactin levels: influence of age, menstrual cycle and oral contraceptives.
    Pansini F; Bianchi A; Zito V; Mollica G; Cavallini AR; Candini GC; Bagni B; Bergamini C; Bassi P
    Contraception; 1983 Sep; 28(3):201-7. PubMed ID: 6641222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic clearance rates of luteinizing hormone in women during different phases of the menstrual cycle and while taking an oral contraceptive.
    Wehmann RE; Blackman MR; Harman SM
    J Clin Endocrinol Metab; 1982 Oct; 55(4):654-9. PubMed ID: 7107812
    [No Abstract]   [Full Text] [Related]  

  • 17. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral contraceptive (ethinyl estradiol and d-norgestrel) on serum prolactin-oestradiol and progesterone levels.
    Erodogan M; Inal A; Ozgu M; Beksac MS; Ergurbuz I
    Acta Reprod Turc; 1980 Jan; 1(3):85-91. PubMed ID: 12262090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.